GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 116 filers reported holding GW PHARMACEUTICALS PLC in Q4 2015. The put-call ratio across all filers is 2.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $178,000 | -55.1% | 821 | -76.0% | 0.00% | -57.1% |
| Q4 2020 | $396,000 | +17.2% | 3,427 | -1.3% | 0.01% | +16.7% |
| Q3 2020 | $338,000 | -22.3% | 3,471 | -2.1% | 0.01% | -25.0% |
| Q2 2020 | $435,000 | -4.6% | 3,545 | -31.9% | 0.01% | -27.3% |
| Q1 2020 | $456,000 | -21.4% | 5,208 | -6.1% | 0.01% | +10.0% |
| Q4 2019 | $580,000 | -10.9% | 5,547 | -2.0% | 0.01% | -16.7% |
| Q3 2019 | $651,000 | -30.0% | 5,662 | +4.9% | 0.01% | -29.4% |
| Q2 2019 | $930,000 | +38.2% | 5,396 | +35.2% | 0.02% | +41.7% |
| Q1 2019 | $673,000 | +47.3% | 3,990 | -14.9% | 0.01% | +33.3% |
| Q4 2018 | $457,000 | -59.6% | 4,690 | -28.3% | 0.01% | -50.0% |
| Q3 2018 | $1,130,000 | -10.2% | 6,542 | -27.4% | 0.02% | -14.3% |
| Q2 2018 | $1,258,000 | +1.1% | 9,014 | -17.7% | 0.02% | 0.0% |
| Q1 2018 | $1,244,000 | -16.2% | 10,948 | -2.7% | 0.02% | -12.5% |
| Q4 2017 | $1,485,000 | +24.9% | 11,249 | -4.0% | 0.02% | +20.0% |
| Q3 2017 | $1,189,000 | -35.0% | 11,714 | -35.8% | 0.02% | -35.5% |
| Q2 2017 | $1,830,000 | -19.2% | 18,253 | -2.5% | 0.03% | -18.4% |
| Q1 2017 | $2,265,000 | -33.5% | 18,727 | -38.5% | 0.04% | -33.3% |
| Q4 2016 | $3,405,000 | -15.9% | 30,467 | -0.1% | 0.06% | -13.6% |
| Q3 2016 | $4,047,000 | +19.2% | 30,490 | -17.8% | 0.07% | +20.0% |
| Q2 2016 | $3,396,000 | +15.7% | 37,089 | -8.8% | 0.06% | +12.2% |
| Q1 2016 | $2,934,000 | +0.3% | 40,667 | -3.5% | 0.05% | +6.5% |
| Q4 2015 | $2,926,000 | -24.8% | 42,142 | -1.0% | 0.05% | -25.8% |
| Q3 2015 | $3,889,000 | +1.4% | 42,563 | +36.4% | 0.06% | +17.0% |
| Q2 2015 | $3,834,000 | +81.7% | 31,210 | +34.8% | 0.05% | +89.3% |
| Q1 2015 | $2,110,000 | +194.3% | 23,154 | +118.7% | 0.03% | +180.0% |
| Q4 2014 | $717,000 | +141.4% | 10,588 | +187.9% | 0.01% | +150.0% |
| Q3 2014 | $297,000 | – | 3,678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |